Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filgrastim”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07131280
What this trial is testing

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis

Who this might be right for
Decompensated Cirrhosis
Institute of Liver and Biliary Sciences, India 110
Testing effectiveness (Phase 2)Study completedNCT00050674
What this trial is testing

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer
Schwartzberg, Lee, M.D. 40
Not applicableUnknownNCT04373395
What this trial is testing

Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Zhejiang University 65
Not applicableStudy completedNCT00596479
What this trial is testing

Filgrastim for the Promotion of Collateral Growth in Patients With CAD

Who this might be right for
Coronary Artery Disease
Insel Gruppe AG, University Hospital Bern 50
Not applicableStudy completedNCT02786719
What this trial is testing

High-Risk Neuroblastoma Chemotherapy Without G-CSF

Who this might be right for
Neuroblastoma
Baylor College of Medicine 13
Not applicableStudy completedNCT02236065
What this trial is testing

Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders

Who this might be right for
Brain InjuryCerebral PalsyAmyotrophic Lateral Sclerosis+1 more
MinYoung Kim, M.D. 10
Testing effectiveness (Phase 2)Study completedNCT00002833
What this trial is testing

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Ended earlyNCT03407430
What this trial is testing

Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain

Who this might be right for
Breast CancerLymphomaPain
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02215200
What this trial is testing

ATG-GCSF in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89
Testing effectiveness (Phase 2)Study completedNCT00004899
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Northwestern University
Early research (Phase 1)Study completedNCT01074060
What this trial is testing

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
City of Hope Medical Center 18
Large-scale testing (Phase 3)Study completedNCT01079676
What this trial is testing

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Who this might be right for
Neutropenia in Breast Cancer
Eurofarma Laboratorios S.A. 220
Early research (Phase 1)Study completedNCT00458250
What this trial is testing

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Tehran University of Medical Sciences 10
Post-approval studies (Phase 4)WithdrawnNCT02408991
What this trial is testing

Use Art-assist and Neupogen to Treat Chronic Limb Ischemia

Who this might be right for
Lower Limb Ischemia
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT00004215
What this trial is testing

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
AnemiaLeukemiaNeutropenia+1 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT06958614
What this trial is testing

Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC

Who this might be right for
Stage II-III Non-small Cell Lung CancerConcurrent ChemotherapyConditions Influencing Health Status
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 213
Post-approval studies (Phase 4)Looking for participantsNCT05753618
What this trial is testing

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy

Who this might be right for
Early-stage Breast Cancer
Ottawa Hospital Research Institute 242
Post-approval studies (Phase 4)UnknownNCT03703674
What this trial is testing

GCSF in Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Not applicableStudy completedNCT03323541
What this trial is testing

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

Who this might be right for
Multiple MyelomaNon-hodgkin LymphomaHodgkin Lymphoma
University Hospital, Brest 62
Testing effectiveness (Phase 2)UnknownNCT02027220
What this trial is testing

Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
MyelomaBortezomibCyclophosphamide+2 more
Second Affiliated Hospital of Soochow University 60
Next Page